Douglas Kerr
Chief Medical Officer at Dyne Therapeutics, Inc. (DYN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $233K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 3,745163,854 held (−2%) | $24.35 | $91K | -31.7% |
| Sep 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,290162,564 held (−1%) | $18.88 | $24K | -11.9% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,556167,599 held (−1%) | $26.28 | $41K | -36.7% |
| Jun 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 887169,155 held (−1%) | $18.33 | $16K | -9.2% |
| May 14SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 1,564170,042 held (−1%) | $18.36 | $29K | -9.4% |
| Mar 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 904171,606 held (−1%) | $14.90 | $13K | +11.7% |
| Dec 5SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 88087,510 held (−1%) | $20.72 | $18K | -19.7% |
- Sell
Chief Medical Officer Douglas Kerr sold $91K of DYN at $24.35 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Douglas Kerr sold $24K of DYN at $18.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Douglas Kerr sold $41K of DYN at $26.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Douglas Kerr sold $16K of DYN at $18.33 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Douglas Kerr sold $29K of DYN at $18.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Douglas Kerr sold $13K of DYN at $14.90 — pre-scheduled 10b5-1 plan sale.